RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Manufacturer profile

ModHike Private Limited

Every published regulatory action recorded against this manufacturer, across all African authorities Drug Eye Africa monitors. Built strictly from published regulatory decisions and nothing else.

What these numbers are. They are counts of published regulatory actions recorded on this register. They are not a finding about the company, not an allegation, and not a measure of product quality. A manufacturer appearing here has had actions published against named products by named authorities; the actions speak for themselves and each one links to its primary notice.
4
Recorded actions
1
Countries
1
Authorities
0
Class I actions recorded

Recorded actions

4 shown
ReferenceDateCtryProductBatchesActionClassSource
DEA-RW-2025-8185011225 Aug 2025RWPROSTREP 20/20 INJ 100ml (Procaine Benzyl Penicillin 200mg, Dihydrostreptomycin Sulphate 200mg)
ModHike Private Limited
MV32-004RecallClass IITier 1 · Regulator-published
DEA-RW-2025-6673969425 Aug 2025RWPROSTREP 20/20 INJ 100ml (Procaine Benzyl Penicillin 200mg, Dihydrostreptomycin Sulphate 200mg)
ModHike Private Limited
MV32-005RecallClass IITier 1 · Regulator-published
DEA-RW-2025-3379872325 Aug 2025RWPROSTREP 20/20 INJ 100ml (Procaine Benzyl Penicillin 200mg, Dihydrostreptomycin Sulphate 200mg)
ModHike Private Limited
MV32-002RecallClass IITier 1 · Regulator-published
DEA-RW-2025-1529488925 Aug 2025RWPROSTREP 20/20 INJ 100ml (Procaine Benzyl Penicillin 200mg, Dihydrostreptomycin Sulphate 200mg)
ModHike Private Limited
MV32-003RecallClass IITier 1 · Regulator-published

Counts are of published regulatory actions recorded on this register. They are not a finding about the company, and this page says so.

Names as published

The issuing authorities published this name as: ModHike Private Limited.

Company response

No response filed. Any named company may register and publish a reply beside these records, and the invitation is logged whether or not it is answered.

How this page is built

  • Published regulator decisions only — no press reports, no allegations
  • Name matching is conservative: only corporate-form suffixes are stripped, and a name that would reduce to a single token is kept whole
  • Every action links to its primary notice